Medicenna Therapeutics Corp. ( MDNAF) - Stock Earnings
MDNAF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 16, 2026, midnight | — / — | — | — / — | — |
MDNAF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | -4.2 million CAD | — CAD |
| 2026Q2 | -5.1 million CAD | — CAD |
| 2026Q3 | -4.0 million CAD | — CAD |
MDNAF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -25.5 million CAD | — CAD |
| 2025 | -11.8 million CAD | — CAD |
| 2026 | -18.4 million CAD | — CAD |
MDNAF
Price: $0.14
52 week price:
Earnings Per Share: -0.16 USD
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 24.1 million